Greetings folks,

The following questions that arose on the chat for Tuesday's meeting and presentation by Alex Keroghlian and Chris Grasso from Fenway Health have been submitted. Will update this thread when they respond:

1) What can national organizations collecting (voluntary and mandatory) health data and providing aggregate reports and analyses on this data, do to have a positive impact and ultimately to improve health outcomes?

2) Does Fenway collect organ inventory on all patients or just trans / nonbinary patients?

3) Re: data aggregation, how do you recommend combining different terms for rolling up to higher organizational levels while protecting patient privacy (e.g., small cell sizes)?